Search

Your search keyword '"Maxim Norkin"' showing total 3 results
Start Over Author "Maxim Norkin" Publisher s. karger ag
3 results on '"Maxim Norkin"'

1. Editorial Board / Contents / Imprint

Author

Laura Denne, Melanie Kripp, Matthias Schulze, Andreas Kirsch, Jessica M. Schmit, Andreas Kutscheidt, Alexander Stein, Xihui Qiu, Dirk Tummes, Druck, Maxim Norkin, Julia Quidde, Jess DeLaune, Jiongyu Chen, Alan Grosbach, De Zeng, Jörg Seraphin, Hui Lin, Xiao Wu, Chen Chen, Dirk Arnold, Manfred Kindler, Miaojun Wang, Danxia Lin, and Volker Petersen

Subjects
Gerontology, Cancer Research, Oncology, business.industry, Library science, Medicine, Hematology, Editorial board, business
Published
2016

2. A Case of Plasmablastic Lymphoma Achieving Complete Response and Durable Remission after Lenalidomide-Based Therapy

Author

Jess DeLaune, Maxim Norkin, Alan Grosbach, and Jessica M. Schmit

Subjects
Male, Oncology, Epstein-Barr Virus Infections, Cancer Research, medicine.medical_specialty, Computed Tomography Angiography, education, Dexamethasone, AIDS-related lymphoma, 03 medical and health sciences, 0302 clinical medicine, immune system diseases, HIV Seronegativity, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, B-cell lymphoma, Cyclophosphamide, Lenalidomide, Computed tomography angiography, Aged, 80 and over, medicine.diagnostic_test, business.industry, Remission Induction, hemic and immune systems, Hematology, Prognosis, medicine.disease, Thalidomide, Lymphoma, Non-Hodgkin's lymphoma, Sigmoid Neoplasms, 030220 oncology & carcinogenesis, Plasmablastic Lymphoma, business, Plasmablastic lymphoma, 030215 immunology, medicine.drug
Abstract

Background: Plasmablastic lymphoma (PBL) is an uncommon variant of diffuse large B-cell lymphoma that is characterized by its plasmacytoid features, aggressive tendencies, and frequent association with human immunodeficiency virus (HIV) infection or other immunocompromised states. Multi-agent, intensive chemotherapy regimens are recommended as first-line treatment by the National Comprehensive Cancer Network. However, the toxicity of these regimens is high and prognosis remains poor. Case Report: We report a patient with HIV-negative PBL who achieved complete response and durable remission using a lenalidomide-based chemotherapy regimen as first-line therapy. Conclusion: Cyclophosphamide, lenalidomide, dexamethasone (CRD) may provide an alternative initial therapeutic option for patients with PBL who cannot tolerate the intensive chemotherapy regimens currently recommended.

Published
2017

3. Konsensusempfehlungen deutscher Experten - Management der Therapie mit Idelalisib

Author

Druck, Jiongyu Chen, Melanie Kripp, Laura Denne, Dirk Tummes, Danxia Lin, Chen Chen, Matthias Schulze, Volker Petersen, Alexander Stein, Jess DeLaune, Jessica M. Schmit, Julia Quidde, Hui Lin, Andreas Kirsch, Manfred Kindler, Alan Grosbach, Miaojun Wang, Xiao Wu, Dirk Arnold, Jörg Seraphin, Maxim Norkin, Andreas Kutscheidt, Xihui Qiu, and De Zeng

Subjects
Cancer Research, Oncology, Hematology
Published
2017

Catalog

Books, media, physical & digital resources
See catalog results